Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand
Primary Purpose
Adhesion of Flexor Tendon of Hand
Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Collagenase
Collagenase injection
Sponsored by
About this trial
This is an interventional treatment trial for Adhesion of Flexor Tendon of Hand focused on measuring Flexor Tendon Adhesions, Zone II of the Hand
Eligibility Criteria
Inclusion Criteria: zone II flexor tendon adhesion of at least one finger Exclusion Criteria: any chronic, serious or uncontrolled medical condition inability to conform to study visits (12-15 per year)
Sites / Locations
- Dept. Orthopaedics, SUNY@Stony Brook
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Collagenase Injection
Arm Description
Injection of collagenase into adhesion restricting tendon gliding
Outcomes
Primary Outcome Measures
Restoration of PIP and DIP joint motion.
Secondary Outcome Measures
Hand Grip strength (kg)
Full Information
NCT ID
NCT00261209
First Posted
November 30, 2005
Last Updated
April 20, 2016
Sponsor
Stony Brook University
1. Study Identification
Unique Protocol Identification Number
NCT00261209
Brief Title
Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand
Official Title
Study of Collagenase Injection Therapy for Treatment of Zone II Flexor Tendon Adhesions in the Hand
Study Type
Interventional
2. Study Status
Record Verification Date
April 2016
Overall Recruitment Status
Completed
Study Start Date
January 2005 (undefined)
Primary Completion Date
January 2008 (Actual)
Study Completion Date
January 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stony Brook University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to dissolve flexor tendon adhesions associated with failed tendon repair surgery.
Detailed Description
In an open label study, collagenase injection therapy was investigated in 3 subjects for it's ability to lyse flexor tendon adhesions in zone II of the hand.
Results indicate that two of three subjects had improved range of finger motion at the PIP and DIP joints. This may obviate the need for patients to have tenolysis hand surgery to correct the finger flexion contracture of the PIP and DIP joints. Detailed controlled studies remain to be done.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adhesion of Flexor Tendon of Hand
Keywords
Flexor Tendon Adhesions, Zone II of the Hand
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
3 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Collagenase Injection
Arm Type
Experimental
Arm Description
Injection of collagenase into adhesion restricting tendon gliding
Intervention Type
Drug
Intervention Name(s)
Collagenase
Other Intervention Name(s)
Collagenase Clostridium Histolyticum
Intervention Description
Collagenase injection into adhesion restricting tendon gliding
Intervention Type
Drug
Intervention Name(s)
Collagenase injection
Other Intervention Name(s)
Collagenase Clostridium Histolyticum
Intervention Description
injection of collagenase into adhesion restricting tendon gliding
Primary Outcome Measure Information:
Title
Restoration of PIP and DIP joint motion.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Hand Grip strength (kg)
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
zone II flexor tendon adhesion of at least one finger
Exclusion Criteria:
any chronic, serious or uncontrolled medical condition
inability to conform to study visits (12-15 per year)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie A Badalamente, PhD
Organizational Affiliation
Dept. Orthopaedics, SUNY@Stony Brook, NY 11794
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Edward Wang, MD
Organizational Affiliation
Dept. Orthopaedics, SUNY@Stony Brook, NY 11794
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept. Orthopaedics, SUNY@Stony Brook
City
Stony Brook
State/Province
New York
ZIP/Postal Code
11794
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand
We'll reach out to this number within 24 hrs